Papers/PMID:32492138
No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial.
The American journal of clinical nutrition2020The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
resveratrol — decreases glycated haemoglobin (HbA1c)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“The adjusted means showed that postintervention HbA1c was lower on resveratrol (35.8 ± 0.43 mmol/mol) compared with placebo (37.6 ± 0.44 mmol/mol).”
Quoted verbatim from No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial.. - Study
- RCT
- Dose
- 150 mg/d
- Population
- Overweight men and women, BMI 27-35 kg/m2, aged 40-70 y; resveratrol versus placebo, postintervention ANCOVA-adjusted means
No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial.2020PMID:32492138Permalink